BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10499273)

  • 1. Production of tissue factor in CD14-expressing human umbilical vein endothelial cells by lipopolysaccharide.
    Chakravortty D; Kato Y; Koide N; Sugiyama T; Kawai M; Fukada M; Yoshida T; Yokochi T
    FEMS Microbiol Lett; 1999 Sep; 178(2):235-9. PubMed ID: 10499273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells.
    Read MA; Cordle SR; Veach RA; Carlisle CD; Hawiger J
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9887-91. PubMed ID: 7694295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells.
    Golenbock DT; Bach RR; Lichenstein H; Juan TS; Tadavarthy A; Moldow CF
    J Lab Clin Med; 1995 May; 125(5):662-71. PubMed ID: 7537790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scoparone inhibits tissue factor expression in lipopolysaccharide-activated human umbilical vein endothelial cells.
    Lee YM; Hsiao G; Chang JW; Sheu JR; Yen MH
    J Biomed Sci; 2003; 10(5):518-25. PubMed ID: 12928592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD14 and lipopolysaccharide-binding protein from bovine serum enable bacterial lipopolysaccharide-mediated cytotoxicity and activation of bovine vascular endothelial cells in vitro.
    Yang Z; Breider MA; Carroll RC; Miller MS; Bochsler PN
    J Leukoc Biol; 1996 Feb; 59(2):241-7. PubMed ID: 8603996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible involvement of toll-like receptor 4 in endothelial cell activation of larger vessels in response to lipopolysaccharide.
    Hijiya N; Miyake K; Akashi S; Matsuura K; Higuchi Y; Yamamoto S
    Pathobiology; 2002; 70(1):18-25. PubMed ID: 12415188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of interleukin-4 on tumour necrosis factor-alpha induced expression of tissue factor and plasminogen activator inhibitor-1 in human umbilical vein endothelial cells.
    Martin NB; Jamieson A; Tuffin DP
    Thromb Haemost; 1993 Dec; 70(6):1037-42. PubMed ID: 8165597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense oligodeoxynucleotide against tissue factor inhibits human umbilical vein endothelial cells injury induced by anoxia-reoxygenation.
    Yin J; Luo XG; Yu WJ; Liao JY; Shen YJ; Zhang ZW
    Cell Physiol Biochem; 2010; 25(4-5):477-90. PubMed ID: 20332629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anisodamine counteracts lipopolysaccharide-induced tissue factor and plasminogen activator inhibitor-1 expression in human endothelial cells: contribution of the NF-kappa b pathway.
    Ruan QR; Zhang WJ; Hufnagl P; Kaun C; Binder BR; Wojta J
    J Vasc Res; 2001; 38(1):13-9. PubMed ID: 11173990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of HUVEC tissue factor synthesis by antisense oligodeoxynucleotide.
    Stephens AC; Ranlall NF; Rivers RP
    Thromb Res; 2008; 122(1):99-107. PubMed ID: 17920661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modification of membrane lipid of human umbilical vein endothelia cells after direct lipopolysaccharide injury].
    Wang X; Cai SX; Luo XD; Wang P; Luo Q; Liang GP; Yang ZC
    Sheng Li Xue Bao; 2001 Dec; 53(6):419-24. PubMed ID: 11930218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemoglobin enhances the production of tissue factor by endothelial cells in response to bacterial endotoxin.
    Roth RI
    Blood; 1994 May; 83(10):2860-5. PubMed ID: 8180381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anisodamine inhibits endotoxin-induced tissue factor expression in human endothelial cells.
    Ruan Q; Song J; Deng Z
    J Huazhong Univ Sci Technolog Med Sci; 2002; 22(4):273-5, 278. PubMed ID: 12674755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD14 and tissue factor expression by bacterial lipopolysaccharide-stimulated bovine alveolar macrophages in vitro.
    Yang Z; Carter CD; Miller MS; Bochsler PN
    Infect Immun; 1995 Jan; 63(1):51-6. PubMed ID: 7528735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of tissue factor induced by IL-6 in HUVEC].
    Tang XL; Jiang ZY; Dong J; Liu XC; Cai SY; Xiao R; Lu YR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):234-7. PubMed ID: 16608083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood.
    Souter PJ; Thomas S; Hubbard AR; Poole S; Römisch J; Gray E
    Crit Care Med; 2001 Jan; 29(1):134-9. PubMed ID: 11176173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemoglobin enhances the binding of bacterial endotoxin to human endothelial cells.
    Roth RI
    Thromb Haemost; 1996 Aug; 76(2):258-62. PubMed ID: 8865542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan oligosaccharides inhibit the expression of interleukin-6 in lipopolysaccharide-induced human umbilical vein endothelial cells through p38 and ERK1/2 protein kinases.
    Liu HT; Li WM; Li XY; Xu QS; Liu QS; Bai XF; Yu C; Du YG
    Basic Clin Pharmacol Toxicol; 2010 May; 106(5):362-71. PubMed ID: 19929981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor.
    Cermak J; Key NS; Bach RR; Balla J; Jacob HS; Vercellotti GM
    Blood; 1993 Jul; 82(2):513-20. PubMed ID: 8329706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies.
    Vega-Ostertag M; Casper K; Swerlick R; Ferrara D; Harris EN; Pierangeli SS
    Arthritis Rheum; 2005 May; 52(5):1545-54. PubMed ID: 15880836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.